Pharmaceuticals firm Slovakofarma says a recent illegal drug manufacture scandal involving one of its employees will not hurt the prospective acquisition of its majority owner, the Czech GV Pharma, by the US fund Warburg Pincus.
Compiled by Tom Nicholson from press reports.
The Slovak Spectator cannot vouch for the accuracy of the information presented in its Flash News postings.
